Overview

Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin

Status:
Withdrawn

Trial end date:
2011-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether aggressive (goal pre-prandial blood glucose <110 mg/dl) versus conservative (goal pre-prandial blood glucose <180mg/dl) diabetes treatment of type 2 diabetic patients on the general medical wards has any effect on hospital outcomes.

Phase:

Phase 4

Details

Lead Sponsor:

University of Texas Southwestern Medical Center

Collaborator:

Novo Nordisk A/S

Treatments:

Insulin
Insulin Aspart
Insulin Detemir
Insulin, Globin Zinc